Fem-Dophilus contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.
/* Mark the container as a query container */
.image-container {
container-type: inline-size;
}
/* When the container’s width is at least 500px, apply a max-width style to the image */
@container (min-width: 500px) {
.image-container img {
max-width: 80%;
height: auto;
}
}
Choosing a selection results in a full page refresh.